The CARDS toxin of


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 27 09 2022
accepted: 10 11 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 21 12 2022
Statut: epublish

Résumé

Within the past 3-5 years, Previous protein microarray studies have shown a differential expression of CXCL9 after The CXCL9 expression level was upregulated among patients with a higher fever peak, fever duration of greater than 7 days, an imaging manifestation of lobar or segmental, or combined pleural effusion ( Our findings suggest that CARDS toxin induces a type 1 immune response positive feedback loop during

Sections du résumé

Background
Within the past 3-5 years,
Methods
Previous protein microarray studies have shown a differential expression of CXCL9 after
Results
The CXCL9 expression level was upregulated among patients with a higher fever peak, fever duration of greater than 7 days, an imaging manifestation of lobar or segmental, or combined pleural effusion (
Conclusions
Our findings suggest that CARDS toxin induces a type 1 immune response positive feedback loop during

Identifiants

pubmed: 36532054
doi: 10.3389/fimmu.2022.1054788
pmc: PMC9752573
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1054788

Informations de copyright

Copyright © 2022 Wang, Sun, Lu, Jiang, Dai, Huang, Wang, Zhu, Wang, Hao, Yan and Chen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Med. 2021 Mar 22;10(6):
pubmed: 33810090
N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
Biochem Biophys Res Commun. 2019 Mar 19;510(4):565-572
pubmed: 30739785
Sci Rep. 2020 Nov 4;10(1):19061
pubmed: 33149220
Comput Struct Biotechnol J. 2021 Apr 24;19:2518-2525
pubmed: 34025940
Pediatr Infect Dis J. 2018 Dec;37(12):e336-e338
pubmed: 29912842
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Front Microbiol. 2021 Nov 19;12:766591
pubmed: 34867898
Int Immunopharmacol. 2021 Aug;97:107823
pubmed: 34102486
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Biochem Biophys Res Commun. 2022 Feb 26;594:81-87
pubmed: 35078111
Clin Microbiol Rev. 2017 Jul;30(3):747-809
pubmed: 28539503
Int J Med Microbiol. 2015 Oct;305(7):705-8
pubmed: 26319941
Int J Mol Sci. 2018 Jul 28;19(8):
pubmed: 30060570
Clin Infect Dis. 2019 Jan 1;68(1):5-12
pubmed: 29788037
Blood. 2020 Jul 23;136(4):501-515
pubmed: 32291445
Front Microbiol. 2016 Mar 31;7:414
pubmed: 27065977
Microorganisms. 2021 Dec 10;9(12):
pubmed: 34946154
Cytokine. 2011 May;54(2):218-21
pubmed: 21356600
Blood. 2000 Nov 1;96(9):3029-39
pubmed: 11049981
Cell Immunol. 2018 Sep;331:100-109
pubmed: 29909072
Antimicrob Agents Chemother. 2009 Apr;53(4):1546-51
pubmed: 19139287
J Microbiol Immunol Infect. 2021 Aug;54(4):673-679
pubmed: 32299786
PLoS One. 2010 Jan 13;5(1):e8668
pubmed: 20084270
Sci Rep. 2021 Jun 2;11(1):11571
pubmed: 34078958
Int Immunopharmacol. 2020 Mar;80:106210
pubmed: 31972425
RNA Biol. 2020 Jun;17(6):755-764
pubmed: 32050839
Stem Cells Transl Med. 2017 Mar;6(3):1018-1028
pubmed: 28186708
Front Microbiol. 2022 Jun 13;13:911228
pubmed: 35770160
PLoS One. 2018 Jan 29;13(1):e0191951
pubmed: 29377957
Front Immunol. 2018 Jan 15;8:1970
pubmed: 29379506
Front Immunol. 2021 Dec 06;12:763292
pubmed: 34938289
Mol Med. 2019 Aug 9;25(1):38
pubmed: 31399022
Curr Opin Rheumatol. 2018 Jul;30(4):380-387
pubmed: 29432224
Pharmacol Res. 2012 Dec;66(6):536-43
pubmed: 22989505
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Am J Respir Cell Mol Biol. 2021 Jan;64(1):143-146
pubmed: 33385212
Front Microbiol. 2016 Apr 12;7:513
pubmed: 27148202
Ann Transl Med. 2020 Mar;8(6):386
pubmed: 32355830
J Infect Dis. 2020 Aug 4;222(5):746-754
pubmed: 32563194
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):281-291
pubmed: 32948415
Sci Rep. 2019 Nov 28;9(1):17853
pubmed: 31780733

Auteurs

Ting Wang (T)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Huiming Sun (H)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Zhitao Lu (Z)

Department of Pediatrics, Zhangjiagang No.1 People's Hospital, Affiliated Hospital of Soochow University, Suzhou, China.

Wujun Jiang (W)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Ge Dai (G)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Li Huang (L)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Meijuan Wang (M)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Canhong Zhu (C)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Yuqing Wang (Y)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Chuangli Hao (C)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Yongdong Yan (Y)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Zhengrong Chen (Z)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH